López Galindo, MónicaBagán Sebastián, José Vicente2015-11-202015-11-202015López-Galindo, M., & Bagán, J. V. (2015). Apixaban and oral implications. Journal of clinical and experimental dentistry, 7(4), e528.19895488http://hdl.handle.net/11268/4582Thrombotic disorders remain a leading cause of death in the Western world, and in this regard a number of anticoagulation treatment have been used, including heparins, fondaparinux, vitamin K antagonists (warfarin, acenocoumarol), and new oral anticoagulants such as apixaban. For years there has been great controversy regarding the use of anticoagulants in planning dental treatments that imply bleeding. The main concerns about using new oral anticoagulants in invasive dental procedures are bleeding due to the lack of an antidote, and the thrombotic risk of the disease for which anticoagulation was indicated in the first place.engApixabanDental treatmentDental implicationsjournal article10.4317/jced.52470restricted accessMedicamentosOdontologíaMedicamentoOdontología